{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T16:01:16Z","timestamp":1745769676455},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.lpm.2009.04.005","type":"journal-article","created":{"date-parts":[[2009,5,16]],"date-time":"2009-05-16T08:26:06Z","timestamp":1242462366000},"page":"34-41","source":"Crossref","is-referenced-by-count":3,"title":["Infections \u00e0 cytom\u00e9galovirus et autres viroses du groupe herp\u00e8s au cours des maladies syst\u00e9miques"],"prefix":"10.1016","volume":"39","author":[{"given":"Christian","family":"Michaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Morlat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2009.04.005_bib1","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00002030-200005260-00017","article-title":"Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy","volume":"14","author":"Salmon-C\u00e9ron","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.lpm.2009.04.005_bib2","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2003-10-3616","article-title":"The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy","volume":"103","author":"Boeckh","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2009.04.005_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/08916930500285667","article-title":"Human cytomegalovirus in patients with systematic lupus erythematosus","volume":"38","author":"Hrycek","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.lpm.2009.04.005_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.humpath.2006.06.002","article-title":"Cytomegalovirus-associated cutaneous vasculopathy and scleroderma sans inclusion body change","volume":"38","author":"Magro","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.lpm.2009.04.005_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10156-007-0503-1","article-title":"Adult Still's disease associated with cytomegalovirus infection","volume":"13","author":"Izumikawa","year":"2007","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.lpm.2009.04.005_bib6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0248-8663(00)80003-X","article-title":"Hematologic and immunologic manifestations of primary cytomegalovirus infections in non-immunocompromised hospitalized adults","volume":"21","author":"Bonnet","year":"2000","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.lpm.2009.04.005_bib7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0248-8663(02)00728-2","article-title":"Lupus \u00e9ryth\u00e9mateux diss\u00e9min\u00e9 et herpesviridae\u00a0: \u00e0 propos de trois observations","volume":"23","author":"Bezanahary","year":"2002","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.lpm.2009.04.005_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.revmed.2007.10.007","article-title":"Prise en charge de l\u2019infection \u00e0 cytom\u00e9galovirus symptomatique chez les patients trait\u00e9s par immunosuppresseurs pour une maladie inflammatoire chronique","volume":"29","author":"Tnani","year":"2008","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.lpm.2009.04.005_bib9","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3899\/jrheum.080336","article-title":"Liver involvement in systemic lupus erythematosus\u00a0: case review of 40 patients","volume":"35","author":"Chowdhary","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2009.04.005_bib10","first-page":"1349","article-title":"Incidence of cytomegalovirus reactivation in patients with inflammatory connective tissue diseases who are under immunosuppressive therapy","volume":"31","author":"Mori","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2009.04.005_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10165-006-0470-x","article-title":"Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemia","volume":"16","author":"Yoda","year":"2006","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.lpm.2009.04.005_bib12","first-page":"649","article-title":"Incidence and clinical features of cytomegalovirus infection diagnosed by cytomegalovirus pp65 antigenemia assay during high dose corticosteroid therapy for collagen vascular diseases","volume":"24","author":"Yamashita","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.lpm.2009.04.005_bib13","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/rheumatology\/ken231","article-title":"Clinical characteristics of cytomegalovirus infection in rheumatic diseases\u00a0: multicentre survey in a large patient population","volume":"47","author":"Takizawa","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2009.04.005_bib14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcv.2008.06.002","article-title":"Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy","volume":"43","author":"D\u2019Ovidio","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.lpm.2009.04.005_bib15","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ibd.20131","article-title":"Infliximab and the risk of latent viruses reactivation in active Crohn's disease","volume":"13","author":"Lavagna","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.lpm.2009.04.005_bib16","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/rheumatology\/keh696","article-title":"Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis","volume":"44","author":"Torre-Cisneros","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2009.04.005_bib17","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.3748\/wjg.14.2912","article-title":"Cytomegalovirus colitis in a patient with Behcet's disease receiving tumor necrosis factor alpha inhibitory treatment","volume":"14","author":"Sari","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.lpm.2009.04.005_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1086\/425123","article-title":"Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis","volume":"39","author":"Haerter","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2009.04.005_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00277-007-0397-0","article-title":"Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin's lymphoma patients receiving autologous hematopoietic stem cell transplantation","volume":"87","author":"Lee","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.lpm.2009.04.005_bib20","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1002\/art.22046","article-title":"Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis remission, relapse, and re-treatment","volume":"9","author":"Smith","year":"2006","journal-title":"Arthritis and rheumatism"},{"key":"10.1016\/j.lpm.2009.04.005_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfn430","article-title":"Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis\u00a0: single centre experience with 15 patients","volume":"24","author":"Lovric","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2009.04.005_bib22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1164\/rccm.200507-1144OC","article-title":"Rituximab for refractory Wegener's granulomatosis\u00a0: report of a prospective, open-label pilot trial","volume":"173","author":"Keogh","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2009.04.005_bib23","doi-asserted-by":"crossref","unstructured":"Charlier C, Henegar C, Launay O, Pagnoux C, Berezne A, Bienvenu B et al. Risk factors for major infections in Wegener's granulomatosis\u00a0: analysis of 113 patients. Ann Rheum Dis 2008; 0: ard.2008.088302v2.","DOI":"10.1136\/ard.2008.088302"},{"key":"10.1016\/j.lpm.2009.04.005_bib24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00002281-200309000-00002","article-title":"Infectious complications in SLE after immunosuppressive therapies","volume":"15","author":"Kang","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.lpm.2009.04.005_bib25","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/ard.60.12.1141","article-title":"Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus","volume":"60","author":"No\u00ebl","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2009.04.005_bib26","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1440-1797.2008.00975.x","article-title":"Effects of mycophenolate mofetil for patients with crescentic lupus nephritis","volume":"13","author":"Tang","year":"2008","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.lpm.2009.04.005_bib27","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.2004080686","article-title":"Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis","volume":"16","author":"Chan","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2009.04.005_bib28","doi-asserted-by":"crossref","first-page":"s33","DOI":"10.1177\/096120330501400107","article-title":"Maintenance therapies for proliferative lupus nephritis\u00a0: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide","volume":"14","author":"Contreras","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2009.04.005_bib29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.ki.5001630","article-title":"dutch working party on systemic lupus erythematosus. Azathioprine\/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial","volume":"70","author":"Grootscholten","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2009.04.005_bib30","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.transproceed.2008.02.028","article-title":"Mycophenolate Mofetil\u00a0: Ten years\u2019 experience of a renal transplant unit","volume":"40","author":"Jorge","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.lpm.2009.04.005_bib31","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/591532","article-title":"RESITRA Network of the spanish study group of infection in transplantation","volume":"47","author":"San Juan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2009.04.005_bib32","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.transproceed.2008.03.084","article-title":"Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus\u00a0: a pooled analysis of clinical trials","volume":"40","author":"Demopoulos","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.lpm.2009.04.005_bib33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/591532","article-title":"Impact of current transplantation management on the development of cytomegalovirus disease afte renal transplantation","volume":"47","author":"San Juan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2009.04.005_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-6143.2007.02031.x","article-title":"Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation","volume":"8","author":"Reischig","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.lpm.2009.04.005_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.bmt.1705671","article-title":"Active CMV disease does not always correlate with viral load detection","volume":"40","author":"Ruell","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lpm.2009.04.005_bib36","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","article-title":"Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant","volume":"6","author":"Khoury","year":"2006","journal-title":"Am J Transplan"},{"issue":"301","key":"10.1016\/j.lpm.2009.04.005_bib37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2009.146","article-title":"Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents","volume":"18","author":"Strangfeld","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2009.04.005_bib38","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jbspin.2007.10.011","article-title":"Herpes zoster in patients taking TNFalpha antagonists for chronic inflammatory joint disease","volume":"75","author":"Wendling","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.lpm.2009.04.005_bib39","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/0961203308089428","article-title":"A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis","volume":"17","author":"Lu","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2009.04.005_bib40","article-title":"Long term safety of methotrexate monotherapy in rheumatoid arthritis patients\u00a0: a systematic literature research","author":"Salliot","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2009.04.005_bib41","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/01.inf.0000226841.03751.1f","article-title":"Herpes zoster in juvenile-onset systemic lupus erythematosus\u00a0: incidence, clinical characteristics and risk factors","volume":"25","author":"Lee","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.lpm.2009.04.005_bib42","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.amjmed.2005.06.012","article-title":"Herpes zoster in immunocompromised patients: Incidence, timing, and risk factors","volume":"118","author":"Wung","year":"2005","journal-title":"Am J Med"},{"issue":"197","key":"10.1016\/j.lpm.2009.04.005_bib43","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1086\/522129","article-title":"Strategies for herpes zoster vaccination of immunocompromised patients","volume":"1","author":"Cohen","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2009.04.005_bib44","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21152","article-title":"Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation","volume":"83","author":"Asano-Mori","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.lpm.2009.04.005_bib45","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","article-title":"One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation\u00a0: no evidence of rebound varicella-zoster virus disease after drug discontinuation","volume":"110","author":"Erard","year":"2007","journal-title":"Blood"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498209002279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498209002279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T05:14:04Z","timestamp":1684991644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498209002279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0755498209002279"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2009.04.005","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}